15,583 Shares in LivaNova PLC (NASDAQ:LIVN) Bought by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd bought a new stake in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 15,583 shares of the company's stock, valued at approximately $722,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Central Pacific Bank Trust Division increased its stake in LivaNova by 21.2% during the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company's stock worth $191,000 after acquiring an additional 720 shares during the last quarter. Vestcor Inc purchased a new position in shares of LivaNova in the 4th quarter worth approximately $204,000. Captrust Financial Advisors bought a new position in shares of LivaNova during the 3rd quarter valued at approximately $217,000. Inceptionr LLC bought a new position in shares of LivaNova during the 4th quarter valued at approximately $217,000. Finally, Sanctuary Advisors LLC purchased a new stake in LivaNova during the 3rd quarter valued at $219,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have commented on LIVN shares. Stifel Nicolaus dropped their price objective on shares of LivaNova from $72.00 to $60.00 and set a "buy" rating for the company in a research note on Wednesday, February 26th. Barclays cut their price target on shares of LivaNova from $58.00 to $56.00 and set an "equal weight" rating on the stock in a report on Friday, March 7th. The Goldman Sachs Group decreased their price objective on shares of LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a research note on Monday, March 3rd. Needham & Company LLC restated a "buy" rating and set a $64.00 target price on shares of LivaNova in a research report on Monday, March 17th. Finally, StockNews.com upgraded LivaNova from a "buy" rating to a "strong-buy" rating in a report on Tuesday, March 25th. Two analysts have rated the stock with a hold rating, five have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $61.17.

LivaNova Trading Down 3.3 %

Shares of NASDAQ:LIVN traded down $1.12 during trading on Friday, reaching $33.02. 219,258 shares of the company were exchanged, compared to its average volume of 679,220. The business's fifty day simple moving average is $41.66 and its 200-day simple moving average is $47.44. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. LivaNova PLC has a 12-month low of $32.48 and a 12-month high of $64.47. The firm has a market capitalization of $1.79 billion, a PE ratio of 78.62 and a beta of 0.90.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.